US Edition
India to force drugmakers to upgrade plants after fatal cough syrup crisis
India mandates all drugmakers meet WHO manufacturing standards after toxic cough syrup with 49% diethylene glycol caused 24 child deaths, sparking arrests and bans.
- On Oct 16, India refused drugmakers' requests to extend a year-end deadline to upgrade facilities to WHO standards after tests confirmed toxic Coldrif batches.
- Government laboratory results showed 48.6 per cent diethylene glycol in the Sresan Pharmaceutical Manufacturer's May Coldrif batch, which IPC materials say can be 'fraudulently or unintentionally' used.
- Regional drug inspectors collected samples while at least four pharmacies closed temporarily, community health workers retrieved Coldrif bottles door-to-door, and local physician Praveen Soni was arrested in the probe.
- Amid public outrage, at least 24 children have died after taking the syrup, intensifying anger and damaging India's international reputation as a 'pharmacy of the world' after linked deaths in Africa and Central Asia.
- India's US$50 billion pharmaceutical industry, with about 3,000 companies operating over 10,000 factories, faces warnings that nearly 49% of Himachal Pradesh units could close without extensions, risking shortages.
8 Articles
8 Articles
Exclusive: India to force drugmakers to upgrade plants after fatal cough syrup crisis
India has refused drugmakers' requests to extend a year-end deadline to upgrade manufacturing facilities, amid public anger over the deaths of at least 24 children who consumed locally produced cough syrup.
Sresan Pharma was inspected five times: Health Minister - News Today
The Tamil Nadu government has responded to concerns raised in the Assembly regarding the cough medicine controversy linked to child fatalities. Minister M. Subramanian clarified that the Sresan Pharmaceuticals company, which produced the controversial ‘Coldrif’ cough syrup, had been inspected five times by the state’s Drug Control Department between 2019 and 2022. Following these inspections, fines and production halts were imposed due to regula…
Drugmakers In India Warned As Toxic Cough Syrup Linked To Deaths Of 24 Children
The deaths have been linked to a batch of Coldrif syrup made by Sresan Pharmaceutical Manufacturer in May. Tests found the syrup contained almost 49% diethylene glycol (DEG), nearly 500 times the limit set by India and the World Health Organisation (WHO). India’s Pharmacopoeia Commission (IPC), which sets national drug standards, said in a presentation this week that DEG is sometimes “fraudulently or unintentionally” used in place of more expens…
India To Enforce WHO Drug Manufacturing Standards By Year-End Despite Small Pharma Objections Amid Cough Syrup Deaths
India has turned down requests from smaller drug companies to push back the deadline for upgrading their factories to meet World Health Organization (WHO) standards. This is a very important decision that was made because people were angry and at least 24 children died recently because of toxic cough syrup made in India. The government’s order, which was first given in late 2023, says that all pharmaceutical businesses must spend money on proces…
Coverage Details
Bias Distribution
- 67% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
